The disclosure describes nanocarried and/or microcarried jasmonate compounds and their pharmaceutical compositions, as well as use thereof for treating or preventing angiogenesis-related or NF-&kgr;B-related disorders. Also disclosed are methods of making the nanocarried and/or microcarried compounds and their compositions.